Cytogenetic and Molecular Diagnostic Testing Associated with Prenatal and Postnatal Birth Defects

Overview

Journal Birth Defects Res

Specialties Reproductive Medicine
Toxicology

Date 2020 Mar 3

PMID 32115903

Citations 9

Authors

Stela Z Berisha

Shashi Shetty

Thomas W Prior

Anna L Mitchell

Affiliations

Soon will be listed here.

Abstract

Genetic testing is beneficial for patients and providers when in search of answers to medical problems related to the prenatal or early postnatal period. It can help to identify the cause or confirm a diagnosis associated with developmental delay, intellectual disability, dysmorphic features, heart defects, multiple malformations, short stature, stillbirth, neonatal death, or fertility problems. Genetic testing can be used to rule out single-gene or chromosome abnormalities. Different diagnostic cytogenetic and molecular genetic techniques are applied in clinical genetics laboratories, from conventional ones to the state of the art chromosomal microarrays and next-generation sequencing. Each of the genetic techniques or methods has its strengths and limitations, however different methods complement each-other in trying to identify the genetic variation(s) responsible for a medical condition, especially the ones related to birth defects.

Citing Articles

An infant with trisomy 9 and partial trisomy 12 derived from maternal balanced translocation: A case report and literature review.

Ming S, Zhou Z, Huang Y, Huang Y, Zhong J, Li Y J Int Med Res. 2024; 52(11):3000605241300093.

PMID: 39612314 PMC: 11607743. DOI: 10.1177/03000605241300093.

An Unclassified Deletion Involving the Proximal Short Arm of Chromosome 10: A New Syndrome?.

Santoro G, Incoronato M, Spagnoli E, Gabbiato I, Contini S, Piovan M Genes (Basel). 2024; 15(6).

PMID: 38927586 PMC: 11203018. DOI: 10.3390/genes15060650.

Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.

van der Coelen S, van der Velden J, Nadesapillai S, Braat D, Peek R, Fleischer K Hum Reprod Update. 2024; 30(4):383-409.

PMID: 38452347 PMC: 11215162. DOI: 10.1093/humupd/dmae005.

Evaluation of chromosomal abnormalities in the postnatal cohort: A single-center study on 14,242 patients.

Akalin H, Sahin I, Paskal S, Tan B, Yalcinkaya E, Demir M J Clin Lab Anal. 2023; 38(1-2):e24997.

PMID: 38115218 PMC: 10829689. DOI: 10.1002/jcla.24997.

Prenatal phenotype of Wolf-Hirschhorn syndrome: A case series and literature review.

Tang F, Zeng Y, Wang L, Yin D, Chen L, Xie D Mol Genet Genomic Med. 2023; 11(6):e2155.

PMID: 36849216 PMC: 10265096. DOI: 10.1002/mgg3.2155.

References

Tucker T, Schlade-Bartusiak K, Eydoux P, Nelson T, Brown L . Uniparental disomy: can SNP array data be used for diagnosis?. Genet Med. 2012; 14(8):753-756. DOI: 10.1038/gim.2012.35. View

Davidson C, Zeringer E, Champion K, Gauthier M, Wang F, Boonyaratanakornkit J . Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection. Biotechniques. 2012; 53(3):182-188. DOI: 10.2144/000113913. View

Phadke S . Cytogenetic microarray in prenatal and postnatal diagnosis. Mol Cytogenet. 2014; 7:I32. PMC: 4044556. DOI: 10.1186/1755-8166-7-S1-I32. View

Shaffer L, Agan N, Goldberg J, Ledbetter D, Longshore J, Cassidy S . American College of Medical Genetics statement of diagnostic testing for uniparental disomy. Genet Med. 2001; 3(3):206-11. PMC: 3111049. DOI: 10.1097/00125817-200105000-00011. View

Mailman M, Heinz J, Papp A, Snyder P, Sedra M, Wirth B . Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med. 2002; 4(1):20-6. DOI: 10.1097/00125817-200201000-00004. View

Dugoff L, Norton M, Kuller J . The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016; 215(4):B2-9. DOI: 10.1016/j.ajog.2016.07.016. View

Miller D, Adam M, Aradhya S, Biesecker L, Brothman A, Carter N . Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010; 86(5):749-64. PMC: 2869000. DOI: 10.1016/j.ajhg.2010.04.006. View

Wapner R, Martin C, Levy B, Ballif B, Eng C, Zachary J . Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012; 367(23):2175-84. PMC: 3549418. DOI: 10.1056/NEJMoa1203382. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

10.

Stuppia L, Antonucci I, Palka G, Gatta V . Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci. 2012; 13(3):3245-3276. PMC: 3317712. DOI: 10.3390/ijms13033245. View

11.

Rehm H, Bale S, Bayrak-Toydemir P, Berg J, Brown K, Deignan J . ACMG clinical laboratory standards for next-generation sequencing. Genet Med. 2013; 15(9):733-47. PMC: 4098820. DOI: 10.1038/gim.2013.92. View

12.

Gahl W, Markello T, Toro C, Fajardo K, Sincan M, Gill F . The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med. 2012; 14(1):51-9. PMC: 4098846. DOI: 10.1038/gim.0b013e318232a005. View

13.

South S, Lee C, Lamb A, Higgins A, Kearney H . ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med. 2013; 15(11):901-9. DOI: 10.1038/gim.2013.129. View

14.

Bell S . Ethical Implications of Rapid Whole-Genome Sequencing in Neonates. Neonatal Netw. 2018; 37(1):42-44. DOI: 10.1891/0730-0832.37.1.42. View

15.

Yohe S, Thyagarajan B . Review of Clinical Next-Generation Sequencing. Arch Pathol Lab Med. 2017; 141(11):1544-1557. DOI: 10.5858/arpa.2016-0501-RA. View

16.

Redon R, Ishikawa S, Fitch K, Feuk L, Perry G, Andrews T . Global variation in copy number in the human genome. Nature. 2006; 444(7118):444-54. PMC: 2669898. DOI: 10.1038/nature05329. View

17.

. Diagnostic testing for Prader-Willi and Angleman syndromes: Report of the ASHG/ACMG Test and Technology Transfer Committee. Am J Hum Genet. 1996; 58(5):1085-8. PMC: 1914606. View

18.

Nagaoka S, Hassold T, Hunt P . Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet. 2012; 13(7):493-504. PMC: 3551553. DOI: 10.1038/nrg3245. View

19.

Clark M, Hildreth A, Batalov S, Ding Y, Chowdhury S, Watkins K . Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci Transl Med. 2019; 11(489). PMC: 9512059. DOI: 10.1126/scitranslmed.aat6177. View

20.

Richardson A, Ormond K . Ethical considerations in prenatal testing: Genomic testing and medical uncertainty. Semin Fetal Neonatal Med. 2017; 23(1):1-6. DOI: 10.1016/j.siny.2017.10.001. View